CJC-1295 study doses
The unit after an amount matters, as do the subjects and the question being tested. These figures describe experiments and establish no personal regimen.
Amounts used in the volunteer studies
The published CJC-1295 amounts were tied to body weight. Micrograms/kg means the amount per kilogram of the volunteer’s weight. That unit travels with the figure whenever it is quoted.
| Human study | Amount reported in the study |
|---|---|
| Teichman and colleagues, 2006 | 30 or 60 micrograms/kg, subcutaneous |
| Ionescu and Frohman, 2006 | 60 or 90 micrograms/kg, single subcutaneous dose |
Teichman’s participants were healthy adults aged 21–61. Ionescu and Frohman studied healthy men aged 20–40. The experiments measured hormone responses and persistence; they established no helpful personal treatment amount.
The little “/kg” has more evidential weight, to my mind, than a familiar fixed figure repeated online. It identifies how the experiment expressed exposure. Removing it changes the quantity being described.
The growth-deficient mouse experiment
Alba and colleagues gave GHRH-knockout mice 2 micrograms per dose at 24-, 48- or 72-hour intervals. The once-daily condition normalized body weight and length, while less frequent administration was progressively less effective. The study also found increased pituitary GH mRNA.
The mice had a growth problem caused by an absent GHRH signal. Restoring growth in that model addresses a different question from improving sleep, strength or aging in a healthy adult. I regard the clearly defined deficit as the most useful feature of this experiment; it explains what the restored growth actually means.
CJC-1295 and ipamorelin dosage questions
Controlled human efficacy trials in this record have established no CJC-1295/ipamorelin treatment amount. The two-receptor pharmacological rationale explains interest in the pairing, while the early CJC-1295 human studies concern the compound alone.
The multi-day DAC half-life also establishes no dosing schedule. The form and half-life page separates compound persistence from the periods of raised hormone measurements.
Routes and laboratory preparation
The main volunteer studies used subcutaneous administration. The research record describes freeze-dried laboratory material and negligible oral bioavailability. Laboratory handling details supply no evidence that a preparation is safe for personal use. The route used in an experiment also leaves the question of personal treatment unresolved.